Jakarta, 17 September 2023 – PT Etana Biotechnologies Indonesia (Etana) together with the Indonesian Dialysis Patient Community (KPCDI) held kidney health education with resource person Dr. Dr. Maruhum Bonar H. Marbun, Sp.PD-KGH., FINASIM and dr. Mirna Nurasri Praptini, SpPD-KGH., M.Epid., FINASIM. The topics raised in this education were what to pay attention to during a kidney transplant and how to prevent and treat anemia in chronic kidney patients, which was attended by 150 kidney failure patients from Jakarta and surrounding areas.
Read MoreJakarta, 3 September 2023 – PT Etana Biotechnologies Indonesia (Etana) in collaboration with the DKI Jakarta Health Service (Dinkes) is holding Health education and Cognition of Infectious Disease Management with the theme "Test and Treat Immediately". The health education is a part of the World Hepatitis Day Commemoration of the DKI Jakarta Province that is specifically discusses Hepatitis and Tubercolosis. The speaker for Hepatitis education is Dr. Imelda Maria Loho, Sp. PD., FINASIM who will explain Hepatitis and its Prevention with Vaccination.
Read MoreJakarta, 26 March 2023 - PT Etana Biotechnologies Indonesia (Etana) together with the Indonesian Dialysis Patient Community (KPCDI) held an online health education themed "Choose EPO or Blood Transfusion" with Dr. Afiatin dr. SpPD-KGH., FINASIM, Renal and Hypertension Consultant Internist, Head of HD Installation at Hasan Sadikin Hospital, Bandung. Etana conducts various health education activities in hospitals and hemodialysis units across Indonesia targeting hemodialysis patients, patient families, health workers and internal medicine specialists, kidney and hypertension consultants as part of a series of activities carried out in commemoration of World Kidney Day.
Read MoreJakarta, 20 March, 2023 – PT Etana Biotechnologies Indonesia (Etana), an Indonesian biopharmaceutical company, has secured a new round of investment led by DEG followed by Yunfeng Capital, HighLight Capital and East Ventures. This round of financing will be used for further strengthening the company’s pipeline and portfolio especially in Oncology area to be drug substances manufacturing facilities. Etana is committed to build production capacity for mammalian cell for monoclonal antibodies drug substance to ensure high local content production and technology capability.
Read MoreJakarta, 4 March 2023 - PT Etana Biotechnologies Indonesia (Etana) together with the Indonesian Dialysis Patient Community (KPCDI) held an online health education themed "Anemia in Chronic Kidney Patients: What are the Impacts and Treatments" with speaker dr. Elizabeth Yasmine Wardoyo, Sp.PD-KGH from Fatmawati Hospital, Jakarta. This webinar was held as a series of commemorations of World Kidney Day which falls on March 9, 2023. Etana and KPDCI have been consistently providing education to patients and the public regarding kidney health.
Read MoreJakarta, 07 October 2022 - PT Etana Biotechnologies Indonesia (Etana) today inaugurated a biopharmaceutical factory located in the Pulogadung Industrial Estate, East Jakarta. The inauguration of the factory was carried out by the President of the Republic of Indonesia, Ir. H. Joko Widodo, accompanied by Coordinating Minister for Maritime Affairs and Investment, Luhut Binsar Pandjaitan; Minister of Health, Budi Gunadi Sadikin; and Head of the Food and Drug Administration (BPOM), Penny K. Lukito; and President Director of Etana, Nathan Tirtana.
Read More